Close Menu

NEW YORK – Proscia said on Monday that it is partnering with the University of California, San Francisco with the aim of introducing artificial intelligence into the practice of pathology.

Beginning with prostate cancer, the collaboration will aim to validate the clinical efficacy of computational pathology applications for several high-impact pathology subspecialties, Proscia said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.